Skin disinfection with octenidine dihydrochloride for central venous catheter site care: a double-blind, randomized, controlled trial

Clinical Microbiology and Infection

Volumn 16, Issue 6, 2010, Pages 600-606

  Dettenkofer, M ^a   Wilson, C ^a   Gratwohl, A ^b   Schmoor, C ^a   Bertz, H ^a   Frei, R ^b   Heim, D ^b   Luft, D ^a   Schulz, S ^a   Widmer, A F ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Alcohol; Bloodstream infection; Central venous catheter; Disinfection; Octenidine dihydrochloride

Indexed keywords

2 PROPANOL; OCTENIDINE; PROPANOL;

ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BLOODSTREAM INFECTION; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HUMAN; INFECTION PREVENTION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SKIN BURNING SENSATION; SKIN CULTURE; SKIN DECONTAMINATION; SKIN IRRITATION;

EID: 77953819335     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.02917.x     Document Type: Article

References (32)

1. Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med 2000, 132:391-402.
2. Raad I. Intravascular-catheter-related infections. Lancet 1998, 351:893-898.
3. Widmer AF. Intravascular catheter-associated infections. Schweiz Med Wochenschr 1997, 127:444-456.
4. Mermel L. Infections related to central venous catheters in US intensive-care units. Lancet 2003, 361:1562.
5. Dettenkofer M, Wenzler-Rottele S, Babikir R. Surveillance of nosocomial sepsis and pneumonia in patients with a bone marrow or peripheral blood stem cell transplant: a multicentre project. Clin Infect Dis 2005, 40:926-931.
6. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality. JAMA 1994, 271:1598-1601.
7. Wenzel RP, Edmond MB. The evolving technology of venous access. N Engl J Med 1999, 340:48-50.
8. Digiovine B, Chenoweth C, Watts C, Higgins M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 1999, 160:976-981.
9. Soufir L, Timsit JF, Mahe C, Carlet J, Regnier B, Chevret S. Attributable morbidity and mortality of catheter-related septicemia in critically ill patients: a matched, risk-adjusted, cohort study. Infect Control Hosp Epidemiol 1999, 20:396-401.
10. Rello J, Ochagavia A, Sabanes E. Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med 2000, 162:1027-1030.
11. Blot SI, Depuydt P, Annemans L. Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections. Clin Infect Dis 2005, 41:1591-1598.
12. O'Grady NP, Alexander M, Dellinger EP. Guidelines for the prevention of intravascular catheter-related infections. Centres for Disease Control and Prevention. MMWR Recomm Rep 2002, 51:1-29.
13. Bailey DM, DeGrazia CG, Hoff SJ. Bispyridinamines: a new class of topical antimicrobial agents as inhibitors of dental plaque. J Med Chem 1984, 27:1457-1464.
14. Michel D, Zach GA. Antiseptic efficacy of disinfecting solutions in suspension test in vitro against methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa and Escherichia coli in pressure sore wounds after spinal cord injury. Dermatology 1997, 195(suppl 2):36-41.
15. Goroncy-Bermes P. Investigation of the efficacy of disinfectants against MRSA and Vancomycin-resistant enterococci. Zentralbl Hyg Umweltmed 1998, 201:297-309.
16. Ellabib M, Ghannoum MA, Whittaker PA. Effects of the pyridinamines octenidine and pirtenidine on yeast mitochondrial function. Biochem Soc Trans 1990, 18:342-343.
17. Ghannoum MA, Elteen KA, Ellabib M, Whittaker PA. Antimycotic effects of octenidine and pirtenidine. J Antimicrob Chemother 1990, 25:237-245.
18. Sedlock DM, Bailey DM. Microbicidal activity of octenidine hydrochloride, a new alkanediylbis [pyridine] germicidal agent. Antimicrob Agents Chemother 1985, 28:786-790.
19. Harke HP. Octenidine dihydrochloride, properties of a new antimicrobial agent. Zentralbl Hyg Umweltmed 1989, 188:188-193.
20. Buhrer C, Bahr S, Siebert J, Wettstein R, Geffers C, Obladen M. Use of 2% 2-phenoxyethanol and 0.1% octenidine as antiseptic in premature newborn infants of 23-26 weeks gestation. J Hosp Infect 2002, 51:305-307.
21. Tietz A, Frei R, Dangel M. Octenidine hydrochloride for the care of central venous catheter insertion sites in severely immunocompromised patients. Infect Control Hosp Epidemiol 2005, 26:703-707.
22. Dettenkofer M, Jonas D, Wiechmann C. Effect of skin disinfection with octenidine dihydrochloride on insertion site colonization of intravascular catheters. Infection 2002, 30:282-285.
23. De Angelis C, Drazen JM, Frizelle FA. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. Lancet 2004, 364:911-912.
24. Raad I, Baba M, Bodey GP. Diagnosis of catheter-related-infections: the role of surveillance and targeted quantitative skin cultures. Clin Infect Dis 1995, 20:593-597.
25. Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med 1977, 296:1305-1309.
26. Horan TC, Gaynes RP. Surveillance of nosocomial infections. Appendix A-1: CDC definitions of nosocomial infections. Hospital Epidemiology and Infection Control 2004, 1659-1702. Mayhall CG, eds, 3rd, edn, Philadelphia, Lippincott Williams & Willkins
27. Lan KK, Wittes J. The B-value: a tool for monitoring data. Biometrics 1988, 44:579-585.
28. Raad II, Hohn DC, Gilbreath BJ. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 1994, 15:231-238.
29. Eggimann P, Harbarth S, Constantin MN, Touveneau S, Chevrolet JC, Pittet D. Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet 2000, 355:1864-1868.
30. Pronovost P, Needham D, Berenholtz S. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006, 355:2725-2732.
31. Marschall J, Mermel LA, Classen D. Strategies to prevent central line-associated bloodstream infections in acute care hospitals. Infect Control Hosp Epidemiol 2008, 29(suppl):22-30.
32. Pratt RJ, Pellowe CM, Wilson JA. epic2: National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect 2007, 65(suppl):1-64.